Phase I trial of combined immunotherapy with subcutaneous granulocyte macrophage colony-stimulating factor, low-dose interleukin 2, and interferon α in progressive metastatic melanoma and renal cell carcinoma. Clin. Cancer Res., 6: 1267-1272, 2000. [2] (multiple letters)

Frederick J Meyers, G. C. De Gast

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)4167
Number of pages1
JournalClinical Cancer Research
Issue number10
StatePublished - 2000

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this